FindTrial
Sign In

Acute reactions and dosimetry associated with old and new adjuvant radiation in carcinoma breast

Acute toxicities and dosimetry associated with conventional and hypo fractionated adjuvant radiation in carcinoma breast. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071736
Enrollment
40
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: ACUTE EFFECTS OF ADJUVANT RADIOTHERAPY IN CONVENTIONAL AND HYPO-FRACTIONATED REGIMENS IN CARCINOMA BREAST: COMPARING THE RADIATION EFFECCTS IN BOTH THE REGIMENS. ONE IS CONVENTIONAL 5

Sponsors

Dr.Harikrishna Suresh
Lead Sponsor
Yenepoya University Medical College Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are above the age of 18 years diagnosed with early stage or locally advanced carcinoma breast, has undergone mastectomy or breast conservative surgery who will be required to undergo adjuvant radiotherapy.

Exclusion criteria

Exclusion criteria: PATIENTS WITH METASTATIC DISEASE PATIENTS WITH RELAPSE MENTALLY CHALLENGED PATIENTS

Design outcomes

Primary

MeasureTime frame
To evaluate the acute reactions IN both conventional and hypo fractionated regimens. Timepoint: BEFORE THE STARTING OF THE TREATMENT 0 WEEK DURING THE TREATMENT 4 TH WEEK POST TREATMENT 2 MONTH 6 MONTHS—

Secondary

MeasureTime frame
To assess the quality of lifeTimepoint: At the end of the treatment At 3 MONTHS AND 6 MONTHS AFTER COMPLETION OF THE TREATMENT—

Countries

India

Contacts

Public ContactDr Suryanarayana Kunikullaya

Yenepoya University Medical College Hospital

skunikullaya@yahoo.com9427357641

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026